Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inulin in R/M HNSCC (PRINCESS)
NCT05821751Recruiting
- Sponsor
- Fondazione del Piemonte per l'Oncologia
- Start
- Dec 2021
- Primary completion
- Dec 2024
- Countries
- 1
01
Overview
Open-label trial in head and neck squamous cell carcinoma (HNSCC), sponsored by Fondazione del Piemonte per l'Oncologia. Primary endpoints: Alpha diversity analysis in the Gut Microbiota at 12 months and Beta diversity analysis in the Gut Microbiota at 12 months. Started Dec 2021; status: recruiting.
02
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT05821751.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05821751.